Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients

Journal of Medical Virology

Volumn 84, Issue 6, 2012, Pages 857-865

  Anggorowati, Nungki ^a,b   Yano, Yoshihiko ^a   Heriyanto, Didik Setyo ^a,b   Rinonce, Hanggoro Tri ^a,b   Utsumi, Takako ^a,c   Mulya, Deshinta Putri ^b   Subronto, Yanri Wijayanti ^b   Hayashi, Yoshitake ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GADJAH MADA UNIVERSITY   (Indonesia)

^c AIRLANGGA UNIVERSITY   (Indonesia)

Author keywords

Hepatitis B virus; Hepatitis C virus; Highly active anti retroviral therapy; Human immunodeficiency virus

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ARTICLE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDONESIA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NUCLEOTIDE SEQUENCE; PREVALENCE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CLUSTER ANALYSIS; COINFECTION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INDONESIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PREVALENCE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84859749958     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23293     Document Type: Article

References (39)

1. Abe A, Inoue K, Tanaka T, Kato J, Kajiyama N, Kawaguchi R, Tanaka S, Yoshiba M, Kohara M. 1999. Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol 37: 2899- 2903.
2. Aceijas C, Friedman SR, Cooper HL, Wiessing L, Stimson GV, Hickman M. 2006. Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution. Sex Transm Infect 82: 10- 17.
3. Akkarathamrongsin S, Praianantathavorn K, Hacharoen N, Theamboonlers A, Tangkijvanich P, Tanaka Y, Mizokami M, Poovorawan Y. 2010. Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand. J Med Virol 82: 257- 262.
4. Al-Mohri H, Cooper C, Murphy T, Klein MB. 2005. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med 6: 375- 378.
5. Alter MJ. 2006. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44: S6- S9.
6. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. 2004. HIV and hepatitis C coinfection within the CAESAR study. HIV Med 5: 174- 179.
7. Audsley J, Arrifin N, Yuen LK, Ayres A, Crowe SM, Bartholomeusz A, Locarnini SA, Mijch A, Lewin SR, Sasadeusz J. 2009. Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations. HIV Med 10: 229- 235.
8. Chevaliez S. 2010. Virological tools to diagnose and monitor hepatitis C virus infection. Clin Microbiol Infect 17: 116- 121.
9. Cooley L, Ayres A, Bartholomeusz A, Lewin S, Crowe S, Mijch A, Locarnini S, Sasadeusz J. 2003. Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals. Aids 17: 1649- 1657.
10. Cui C, Shi J, Hui L, Xi H, Zhuoma, Quni, Tsedan, Hu G. 2002. The dominant hepatitis B virus genotype identified in Tibet is a C/D hybrid. J Gen Virol 83: 2773- 2777.
11. Kim AY, Chung RT. 2009. Coinfection with HIV-1 and HCV-A one-two punch. Gastroenterology 137: 795- 814.
12. Kulsudjarit K. 2004. Drug problem in southeast and southwest Asia. Ann N Y Acad Sci 1025: 446- 457.
13. Kumar D, Farrell GC, Fung C, George J. 2002. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response. Hepatology 36: 1266- 1272.
14. Ma Q, Wang Y. 2012. Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol 84: 198- 206.
15. Matthews GV, Bartholomeusz A, Locarnini S, Ayres A, Sasaduesz J, Seaberg E, Cooper DA, Lewin S, Dore GJ, Thio CL. 2006. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. Aids 20: 863- 870.
16. McGovern BH, Ditelberg JS, Taylor LE, Gandhi RT, Christopoulos KA, Chapman S, Schwartzapfel B, Rindler E, Fiorino AM, Zaman MT, Sax PE, Graeme-Cook F, Hibberd PL. 2006. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis 43: 365- 372.
17. Medrano FJ, Sanchez-Quijano A, Pineda J, Lissen E. 1991. Isolated anti-HBc and hepatitis B virus occult infection. Vox Sang 61: 140.
18. Nakano T, Lu L, Liu P, Pybus OG. 2004. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis 190: 1098- 1108.
19. Nelwan EJ, Van Crevel R, Alisjahbana B, Indrati AK, Dwiyana RF, Nuralam N, Pohan HT, Jaya I, Meheus A, Van Der Ven A. 2010. Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: Prevalence, risk factors and implications of HIV screening. Trop Med Int Health 15: 1491- 1498.
20. Okamoto H, Kojima M, Sakamoto M, Iizuka H, Hadiwandowo S, Suwignyo S, Miyakawa Y, Mayumi M. 1994. The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease. J Gen Virol 75: 629- 635.
21. Ramos B, Nunez M, Martin-Carbonero L, Sheldon J, Rios P, Labarga P, Romero M, Barreiro P, Garcia-Samaniego J, Soriano V. 2007. Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients. J Acquir Immune Defic Syndr 44: 557- 561.
22. Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male PJ, Giostra E, Carlotto A, Bozzola L, Smedile A, Negro F. 2004. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut 53: 406- 412.
23. Ruxrungtham K, Brown T, Phanuphak P. 2004. HIV/AIDS in Asia. Lancet 364: 69- 82.
24. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406- 425.
25. Sellier P, Schnepf N, Jarrin I, Mazeron MC, Simoneau G, Parrinello M, Evans J, Lafuente-Lafuente C. 2010. Description of liver disease in a cohort of HIV/HBV coinfected patients. J Clin Virol 47: 13- 17.
26. Sharma M, Oppenheimer E, Saidel T, Loo V, Garg R. 2009. A situation update on HIV epidemics among people who inject drugs and national responses in South-East Asia Region. Aids 23: 1405- 1413.
27. Sheldon J, Ramos B, Garcia-Samaniego J, Rios P, Bartholomeusz A, Romero M, Locarnini S, Zoulim F, Soriano V. 2007. Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity. J Acquir Immune Defic Syndr 46: 279- 282.
28. Simmonds P. 2001. The origin and evolution of hepatitis viruses in humans. J Gen Virol 82: 693- 712.
29. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74: 2391- 2399.
30. Soetjipto, Handajani R, Lusida MI, Darmadi S, Adi P, Soemarto, Ishido S, Katayama Y, Hotta H. 1996. Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia. J Clin Microbiol 34: 2875- 2880.
31. Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. 2010. Viral hepatitis and HIV co-infection. Antiviral Res 85: 303- 315.
32. Sucupira MV, Mello FC, Santos EA, Niel C, Rolla VC, Arabe J, Gomes SA. 2006. Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: High prevalence of occult infection and low frequency of lamivudine resistant mutations. Mem Inst Oswaldo Cruz 101: 655- 660.
33. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. 2002. Hepatitis C and progression of HIV disease. JAMA 288: 199- 206.
34. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596- 1599.
35. Tanimoto T, Nguyen HC, Ishizaki A, Chung PT, Hoang TT, Nguyen VT, Kageyama S, Oka S, Pham VT, Ichimura H. 2010. Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. J Med Virol 82: 1355- 1363.
36. Tokita H, Shrestha SM, Okamoto H, Sakamoto M, Horikita M, Iizuka H, Shrestha S, Miyakawa Y, Mayumi M. 1994. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol 75: 931- 936.
37. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD. 2006. Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study. Arch Intern Med 166: 1632- 1641.
38. Xia X, Lu L, Tee KK, Zhao W, Wu J, Yu J, Li X, Lin Y, Mukhtar MM, Hagedorn CH, Takebe Y. 2008. The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China. J Med Virol 80: 1142- 1152.
39. Yan YX, Gao YQ, Sun X, Wang W, Huang XJ, Zhang T, Li M, Zang CP, Li ZC, Wu H. 2011. Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients. Epidemiol Infect 139: 354- 360.